Infusion Laboratory: Protocol 3 (Risperidone) - 4
Phase 1
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 13
- Registration Number
- NCT00000339
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
Phase 2
Completed
- Conditions
- Cocaine-Related DisordersSubstance-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 60
- Registration Number
- NCT00000274
- Locations
- ๐บ๐ธ
New York State Psychiatric Institute, New York, New York, United States
Role of Metabolites in Nicotine Dependence (3) - 6
Phase 2
Completed
- Conditions
- Tobacco Use Disorder
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000289
- Locations
- ๐บ๐ธ
University of Minnesota, Minneapolis, Minnesota, United States
Cocaine Abuse and Attention Deficit Disorder - 3
Not Applicable
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 32
- Registration Number
- NCT00000268
- Locations
- ๐บ๐ธ
New York State Psychiatric Institute, New York, New York, United States
Acute Withdrawal From Smoked Cocaine - 9
Phase 1
Completed
- Conditions
- Substance-Related DisordersCocaine-Related DisordersSubstance Withdrawal Syndrome
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000292
- Locations
- ๐บ๐ธ
University of Minnesota, Minneapolis, Minnesota, United States
Flupenthixol Decanoate in Methamphetamine Smoking - 1
Phase 2
Completed
- Conditions
- Substance-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 58
- Registration Number
- NCT00000241
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
Phase 2
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 40
- Registration Number
- NCT00000344
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5
Phase 2
Completed
- Conditions
- Opioid-Related DisordersSubstance-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000356
- Locations
- ๐บ๐ธ
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Role of Metabolites in Nicotine Dependence (1) - 1
Phase 2
Completed
- Conditions
- Tobacco Use Disorder
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000284
- Locations
- ๐บ๐ธ
University of Minnesota, Minneapolis, Minnesota, United States
Propranolol for Treatment of Cocaine Addiction - 2
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000197
- Locations
- ๐บ๐ธ
University of Pennsylvania, Philadelphia, Pennsylvania, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath